PTC Therapeutics' Sephience receives US FDA approv...
News
July 29, 2025
PTC Therapeutics' Sephience receives US FDA approval to treat phenylketonuria
29 July 2025 - Biopharmaceutical company PTC Therapeutics Inc (NASDAQ: PTCT) announced on Monday that the US Food and Drug Administration (FDA) has approved SEPHIENCE (sepiapterin) for the treatment o...
29 July 2025 - Biopharmaceutical company PTC Therapeutics Inc (NASDAQ: PTCT) announced on Monday that the US Food and Drug Administration (FDA) has approved SEPHIENCE (sepiapterin) for the treatment o...
Premium Content
This article is available to subscribers only. Subscribe to read the full article.
Category:
Technology